The ototoxic effects of cisplatin in a Sprague-Dawley rat model were evaluated by recordings of auditory brainstem responses (ABR) and transiently evoked otoacoustic emissions (TEOAEs). The ABR responses were evoked from alternating clicks and 8, 10, 12, 16, 20 and 30 kHz tone pips in a range from 40 to 100 dB SPL range. The TEOAEs were recorded with a non-linear protocol, and were evoked by a 63.5 dB SPL click stimulus. Twenty five male Sprague-Dawley rats were used in the study, 20 animals were treated with cisplatin (16 mg/kg, body weight) and five animals served as controls. The data showed that 72 h after the cisplatin administration, the TEOAE and ABR variables were significantly altered. The relationship between the ABR and TEOAE var...
Cisplatin is a highly effective chemotherapeutic agent that is widely used to treat solid organ mali...
Carboplatin is a second generation platinum-containing anti-tumor drug which selectively alters the ...
The early effects of clinical dose of cisplatin (100 mg/m(2)) on distort ion-product otoacoustic emi...
The ototoxic effects of cisplatin in a Sprague-Dawley rat model were evaluated by recordings of audi...
The present study has evaluated the use of distortion product otoacoustic emission (DPOAE) respons...
SummaryCisplatin (cis-diamminedicloroplatinum) is an antineoplastic drug used in the treatment of a ...
The present study has evaluated the use of distortion product otoacoustic emission (DPOAE) respo...
SummaryCisplatin (cis-diamminedicloroplatinum) is an antineoplastic drug used in the treatment of a ...
The aim of this experimental case study was to investigate the cumulative effects of repeated clinic...
BACKGROUND: Sprague-Dawley rats were used as an acute cisplatin ototoxicity model to compare the ch...
SummaryCisplatin is a chemotherapy agent frequently used to treat different types of neoplasia. Otot...
The aim of this study was to investigate the potential protective effect of thymoquinone against cis...
This review critically evaluates the literature on cisplatin ototoxicity and attempts to address the...
SummaryCisplatin is a chemotherapy agent frequently used to treat different types of neoplasia. Otot...
Carboplatin is a second generation platinum-containing anti-tumor drug which selectively alters the ...
Cisplatin is a highly effective chemotherapeutic agent that is widely used to treat solid organ mali...
Carboplatin is a second generation platinum-containing anti-tumor drug which selectively alters the ...
The early effects of clinical dose of cisplatin (100 mg/m(2)) on distort ion-product otoacoustic emi...
The ototoxic effects of cisplatin in a Sprague-Dawley rat model were evaluated by recordings of audi...
The present study has evaluated the use of distortion product otoacoustic emission (DPOAE) respons...
SummaryCisplatin (cis-diamminedicloroplatinum) is an antineoplastic drug used in the treatment of a ...
The present study has evaluated the use of distortion product otoacoustic emission (DPOAE) respo...
SummaryCisplatin (cis-diamminedicloroplatinum) is an antineoplastic drug used in the treatment of a ...
The aim of this experimental case study was to investigate the cumulative effects of repeated clinic...
BACKGROUND: Sprague-Dawley rats were used as an acute cisplatin ototoxicity model to compare the ch...
SummaryCisplatin is a chemotherapy agent frequently used to treat different types of neoplasia. Otot...
The aim of this study was to investigate the potential protective effect of thymoquinone against cis...
This review critically evaluates the literature on cisplatin ototoxicity and attempts to address the...
SummaryCisplatin is a chemotherapy agent frequently used to treat different types of neoplasia. Otot...
Carboplatin is a second generation platinum-containing anti-tumor drug which selectively alters the ...
Cisplatin is a highly effective chemotherapeutic agent that is widely used to treat solid organ mali...
Carboplatin is a second generation platinum-containing anti-tumor drug which selectively alters the ...
The early effects of clinical dose of cisplatin (100 mg/m(2)) on distort ion-product otoacoustic emi...